The GCMS analysis of the ethyl acetate fraction of crude aqeous methanol extract of the root bark of Spondias mombin revealed the composition of 18 compounds of which two methyl esters of long chain carboxylic acids (methyl palmitate and (E)-9-octadecenoic acid methyl ester) account for 52% of the entire extract both having % peak area of 25.6% and 26.4% respectively. The ethyl acetate fraction of the S. mombin aqeous methanolic extract inhibited tyrosinase from Agaricus bisporus (mushroom) with an IC50 of 1.016 ± 0.003 mg/ml which was 25 fold higher than that of kojic acid which was used as a standard inhibitor of tyrosinase in a control experiment with an IC50 of 0.04 ± 0.006 mg/ml. The interaction between the EtOAc fraction of S. mombin and tyrosinase was investigated through fluorescence quenching studies. The fluorescence emission spectra of tyrosinase were recorded in the range of 300 – 500 nm with the excitation and emission wavelengths of tyrosinase at 290 nm and 345 nm respectively. The Intrinsic fluorescence quenching indicated that the test fraction interacted and quenched the fluorescence intensity of tyrosinase in a concentration dependent manner. Kinetic studies with the extract showed that the test fraction elicited a competitive mode of inhibition for the tyrosinase (from A. bisporus). The 3D structures of the 18 compounds detected as constituents of the fraction from GCMS analysis were generated and prepared for docking using a combination of software packages (ChemDraw Ultra 12.0 and MGL tools v1.5.4) and docked (using autodock vina v.1.1.2) with the 3D, X-ray crystallographic structure of the protein (obtained from the protein databank, rcsb.org, pdb code 2Y9X) in order to estimate their binding affinity and interactions with the protein. The docking calculations revealed that five compounds out of the eighteen had higher binding energy (-5.8 kcal/mol to -7.5 kcal/mol) relative to that of the standard, kojic acid (-5.6 kcal/mol). The compound identified to have the highest binding affinity for the tyrosinase is (E)-4-((4-(2-hydroxybenzamido)phenyl)amino)-4-oxobut-2-enoic acid with a binding energy of -7.5 kcal/mol.
| [1] | Ahn S.J., Koketsu M., Ishihara H., et al., “Regulation of melanin synthesis by selenium-containing carbohydrates,” Chem. Pharm. Bull., 54; 281-286, 2006.View Article |
| [2] | Iozumi K., Hoganson G.E., Pennella R., et al., “Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes.” J. Invest. Dermatol., 100; 806-811, 1993.View Article PubMed |
| [3] | Li G., Ju H.K., Chang H.W., et al., “Melanin biosynthesis inhibitors from the bark of Machilus thunbergii.” Biol. Pharm. Bull., 26; 1039-1041, 2003.View Article PubMed |
| [4] | Unver N., Freyschmidt-Paul P., Horster S., et al., “Alterations in the epidermal melanin axis and factor XIIIa melanophages in senile lentigo and ageing skin.” Br. J. Dermatol., 155; 119-128, 2006.View Article PubMed |
| [5] | Brenner M., Hearing V.J., “The protective role of melanin against UV damage in human skin.” Photochem. Photobiol., 84; 539-549, 2008.View Article PubMed |
| [6] | Urabe K., Nakayama J., Hori Y., In Norlund J.J., Boissy R.E., et al. eds. The pigmentary system: physiology and pathophysiology. New York, NY: Oxford University Press; 1998: 909-913.View Article |
| [7] | Asanuma M., Miyazaki., and Ogawa N., “Dopamine or L-DOPA-induced neurotoxicity; the role of dopamine quinone formation and tyrosinase in a model of parkinson’s disease.” Neurotox Res., 5(3):165-176, 2003.View Article PubMed |
| [8] | Nithitanakool S., Pithayanukul P., Bavovada R., and Saparpakorn P., “Molecular Docking Studies and Anti-Tyrosinase Activity of Thai Mango Seed Kernel Extract,” Molecules, 14(1); 257-265, 2009.View Article PubMed |
| [9] | Pillaiyar T., Manickam M., & Namasivayam V., “Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors,” Journal of Enzyme Inhibition and Medicinal chemistry, 32(1); 403-425, 2017.View Article PubMed |
| [10] | Ajao A.O., Shonukan O. and Femi-Onadeko B., “Antibacterial effect of aqueous and alcohol extracts of Spondias mombin, and Alchornea cordifolia-two local antimicrobial remedies.” International Journal of Crude Drug Research, 23(2): 67-72. 1985.View Article |
| [11] | Ayoka, A.O., Akomolafe, R.O., Akinsomisoye, O.S., and Ukponmwan O.E., “Medicinal and economic value of Spondias mombin.” African Journal of Biomedical Research, 11(2); 34-37, 2008.View Article |
| [12] | Elufioye T.O., Obuotor E.M., Agbedahunsi J.M., Adesanya S.A., Anticholinesterase constituents from the leaves of Spondias mombin L. (Anacardiaceae).” Biologics: Targets and Therapy, 11; 107-114, 2017.View Article |
| [13] | Ayoka, A.O., Akomolafe, R.O., Iwalewa, E.O. and Ukponmwan, O.E., “Studies on the anxiolytic effect of Spondias mombin L. (Anacardiaceae) extracts.” African Journal of Traditional, Complementary and Alternative medicines, 2(2); 153-165, 2006.View Article |
| [14] | Ashraf Z., Rafiq M., Seo S.Y., Babar, M.M., and Zaidi N.U.S.S., “Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.” Journal of enzyme inhibition and medicinal chemistry, 30(6); 874-883, 2015.View Article PubMed |
| [15] | Kim D., Park J., Kim J., Han C., Yoon J., Kim N., and Lee C., “Flavonoids as mushroom tyrosinase inhibitors: a fluorescence quenching study.” Journal of agricultural and food chemistry, 54(3); 935-941, 2006.View Article PubMed |
| [16] | Trott O., Olson A.J., “AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading” Journal of Computational Chemistry, 31; 455-461. 2010. PubMed PubMed |
